#Coronavirus Disease Research #References (by AMEDEO, March 28 '26)

 

Emerg Infect Dis

1. FENG PI, Phares CR, Pratt R, Self JL, et al
   Tuberculosis before and during COVID-19 Pandemic, United States, 2010-2023.
   Emerg Infect Dis. 2026;32:388-396.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

2. SCHWEI RJ, Ikenberry H, Griffin M, Werner N, et al
   Optimizing antimicrobial stewardship during operational upheaval: lessons in resiliency from the COVID-19 pandemic.
   Infect Control Hosp Epidemiol. 2026 Mar 26:1-10. doi: 10.1017/ice.2026.10415.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

3. JANG S, Cheong C, Choi WS, Kim KH, et al
   Transitioning to Routine Immunization: Cost-Effectiveness of a National COVID-19 Vaccination Program for Older Adults in South Korea.
   Int J Infect Dis. 2026 Mar 23:108585. doi: 10.1016/j.ijid.2026.108585.
   PubMed         Abstract available
   
   
4. XU Y, Kwek EC, Gene KTE, Conceicao EP, et al
   Trends and Outcomes of COVID-19 Hospital Admissions 'For' vs. 'With' COVID-19 in Singapore: A Retrospective Cohort Study using the SingHealth COVID-19 Registry.
   Int J Infect Dis. 2026 Mar 19:108559. doi: 10.1016/j.ijid.2026.108559.
   PubMed         Abstract available
   
   

   
   Intensive Care Med

5. WEISS SL, Peters MJ, Oczkowski SJW, Belley-Cote E, et al
   Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
   Intensive Care Med. 2026 Mar 23. doi: 10.1007/s00134-026-08360.
   PubMed         Abstract available
   
   

   
   J Med Virol

6. WU W, Rippee-Brooks MD, Adam A, Weinstein KH, et al
   Variant-Specific tRNA-Derived Fragments Induced By Severe Acute Respiratory Syndrome Coronavirus 2: Implications for Disease Outcome Differentiation.
   J Med Virol. 2026;98:e70881.
   PubMed         Abstract available
   
   

   
   J Virol

7. CHEN C, Su G, Wang Y, Xiong Y, et al
   PEX19 restricts porcine deltacoronavirus replication through farnesylation-dependent and -independent mechanisms.
   J Virol. 2026 Mar 24:e0209725. doi: 10.1128/jvi.02097.
   PubMed         Abstract available
   
   
8. BAYUROVA E, Kostyushev D, Tikhonov A, Chulanov V, et al
   Broad-acting antivirals: the pursuit of pan-viral therapeutics in the era of pandemics.
   J Virol. 2026 Mar 23:e0007726. doi: 10.1128/jvi.00077.
   PubMed         Abstract available
   
   

   
   Lancet Infect Dis

9. BIJUKCHHE SM, Marchevsky NG, Kibengo F, Sharma AK, et al
   Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.
   Lancet Infect Dis. 2026 Mar 19:S1473-3099(26)00053.
   PubMed         Abstract available